Previously, researchers assessed the levels of CD8+ TILs in both intra-tumoral and peripheral compartments of the malignant tumor, but the systematic research conducted by Tang et al. (2021) demonstrated that only intratumoral CD8+ TILs are associated with improving disease-free and overall survival [33]. This evidence concerns the gene CD8A and cancer.